Provision of Assay Kits for SCID & SMA In-Service Evaluations - EONIS-Q Revvity
A Contract Award Notice
by NHS ENGLAND
- Source
- Contracts Finder
- Type
- Contract (Products)
- Duration
- 3 year
- Value
- £3M-£4M
- Sector
- HEALTH
- Published
- 12 Mar 2026
- Delivery
- 01 Apr 2026 to 31 Mar 2029
- Deadline
- 12 Mar 2026 12:00
Related Terms
Location
Geochart for 1 buyers and 1 suppliers
1 buyer
- NHS England Leeds
1 supplier
- Revvity Rhondda Cynon Taff
Description
EONIS-Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 4 Screening laboratories, with the addition of the ISE for Spinal Muscular Atrophy (SMA).
Award Detail
| 1 | Revvity (Rhondda Cynon Taff)
|
CPV Codes
- 33100000 - Medical equipments
Indicators
- Contract is suitable for SMEs.
- Contract is suitable for VCOs.
Reference
- CF-3430100D0O000000rwimUAA
- CF d1d6ec3d-8b57-42c2-bcc9-988c98df5b88